首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of psychoactive drugs

缩写:

ISSN:0279-1072

e-ISSN:2159-9777

IF/分区:2.2/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引684
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yuting Yang,Christian P Müller,Darshan Singh Yuting Yang
Kratom has been widely reported to alleviate depression and anxiety; however, its effects on depression and anxiety in people who use methamphetamine (METH) are rarely investigated. This study constructed network structures of kratom use, d...
Carrie Cuttler,Kevin F Boehnke,Mitchell L Doucette et al. Carrie Cuttler et al.
The legalization of cannabis in the United States (US) has increased the availability of a variety of novel cannabinoids such as cannabigerol (CBG) and cannabinol (CBN), delta-8 tetrahydrocannabinol (delta-8 THC) and THC-O acetate ester (TH...
Christopher J Mullin,Lacey C Donahue,Megan T Campbell et al. Christopher J Mullin et al.
The current study examined sex differences in cannabis use motives and whether sex moderated the association between cannabis use motives and cannabis-related problems. Seven hundred and forty-one adults reporting past-month cannabis use co...
Patrick W Corrigan,Sai Snigdha Talluri,Beatrice Wendeln et al. Patrick W Corrigan et al.
Attitudes about cannabis use (CU) are changing, as exemplified by laws in some states and the District of Columbia (DC) legalizing medicinal cannabis with or without recreational use. This study contrasts the effect of changes in DC and sta...
Nicky J Mehtani,Maha N Mian,Gabrielle Agin-Liebes et al. Nicky J Mehtani et al.
Amid an evolving psychedelic drug policy landscape and limitations of existing substance use disorder (SUD) treatments, a novel addiction recovery paradigm has emerged involving augmentation of 12-Step program engagement with therapeutic ps...
James M Zech,Jérémie Richard,Grant M Jones James M Zech
Psychedelic-assisted interventions are emerging as potential treatments for substance use disorders, including alcohol use disorder (AUD). While recent randomized controlled trials suggest efficacy for certain psychedelics and related compo...
Barbara Brett,Christine Bynum Barbara Brett
Posttraumatic stress disorder (PTSD) is a serious and chronic mental health condition with limited effective treatment options. 3,4-methylenedioxymethamphethamine (MDMA)-assisted psychotherapy (MDMA-AT) has shown promise in phase 2 and phas...
John Moore,Namkee Choi,Diana DiNitto John Moore
Approximately 18% of U.S. adults have a substance use disorder (SUD), yet SUD treatment utilization rates remain low. Substance use problem recognition, or one's awareness that their substance use is harmful, is a key precursor to seeking S...
A M Ortiz Bernal,C L Raison,R L Lancelotta et al. A M Ortiz Bernal et al.
5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a psychedelic gaining interest as a potential mental health treatment. However, a poorly characterized phenomenon termed reactivation (similar to "flashbacks") is commonly reported with 5-MeO-...
Anna Bradford,Ethan Freedman,Rachel E Dinero Anna Bradford
In recent years, the potential psychological benefits of psychedelic drugs have garnered increasing interest from academic and medical communities. We conducted a systematic review of literature examining the association between psychedelic...